Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.2800
+0.0700 (3.17%)
NASDAQ· Last Trade: Jul 30th, 9:37 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors